seizures - Nursing Case Study

Pathophysiology

• Primary mechanism: Imbalance between excitatory and inhibitory neurotransmitters in the brain—excessive excitatory neurotransmitter activity (e.g., glutamate) or diminished inhibitory neurotransmitter activity (e.g., GABA) can lead to abnormal electrical discharges, causing seizures.

• Secondary mechanism: Disruption in ion channel function—altered sodium, potassium, or calcium ion channels can lead to abnormal neuronal firing and synchronization, contributing to seizure generation and propagation.

• Key complication: Prolonged seizures may result in neuronal injury and increased risk of future seizures due to brain changes, emphasizing the importance of prompt and effective treatment to prevent further complications.

Patient Profile

Demographics:

43-year-old female, school teacher

History:

• Key past medical history: History of epilepsy diagnosed at age 25, hypertension, and type 2 diabetes

• Current medications: Carbamazepine, Lisinopril, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased frequency of seizures over the past two weeks

• Key symptoms: Confusion post-seizure, occasional dizziness, persistent headache, and mild hand tremors

• Vital signs: Blood pressure 148/92 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F, oxygen saturation 95% on room air

Section 1

Following the initial assessment, the healthcare team decided to perform a series of diagnostic tests to evaluate the increasing frequency of seizures. An electroencephalogram (EEG) was conducted, revealing frequent epileptiform discharges consistent with her history of epilepsy but showing a notable increase in both intensity and frequency. Blood tests indicated subtherapeutic levels of carbamazepine, suggesting that her medication may not be effectively controlling her seizures. Additionally, her blood glucose level was 210 mg/dL, which is above the target range for someone with type 2 diabetes, and her HbA1c was 8.1%, indicating poor long-term glucose control. This raises concerns about the impact of metabolic imbalances on her seizure threshold.

Furthermore, a MRI of the brain was performed to rule out any structural abnormalities that could be contributing to her seizure activity. The MRI results showed no new lesions but did indicate mild cerebral atrophy, which could be an effect of chronic seizure activity or other comorbidities such as hypertension and diabetes. This finding underscores the importance of optimizing her medical management to prevent further neuronal injury.

The clinical team is now considering adjusting her antiepileptic medication regimen to achieve better seizure control while also addressing her hypertension and diabetes more aggressively. This will involve a careful evaluation of potential drug interactions and the need for patient education on lifestyle modifications that could help stabilize her blood pressure and blood glucose levels. Ensuring optimal management of her underlying conditions is crucial to preventing further complications and improving her overall quality of life. As the team deliberates these adjustments, they are closely monitoring her vital signs and neurological status to swiftly identify any changes in her condition.

Section 2

As the clinical team began implementing the revised treatment plan, they closely monitored the patient's response to the new interventions. Her antiepileptic medication regimen was adjusted, increasing the dose of carbamazepine while introducing levetiracetam to provide additional control over her seizure activity. This change required vigilant monitoring of her drug levels and potential side effects. Concurrently, her diabetes management was intensified, with the introduction of a GLP-1 receptor agonist to help improve her glycemic control alongside dietary modifications and increased physical activity. Her blood pressure was also managed with a slight increase in her lisinopril dosage to address her hypertension more effectively.

Over the next few days, the patient exhibited a notable reduction in seizure frequency and intensity, suggesting a positive response to the new antiepileptic regimen. However, her blood glucose levels remained somewhat erratic, with occasional spikes above 180 mg/dL despite the new diabetic management approach. Her blood pressure readings improved, averaging around 130/80 mmHg, indicating better control. Vital signs were regularly monitored: her heart rate was stable at 78 bpm, and her respiratory rate remained at 16 breaths per minute. Despite these encouraging signs, the patient began to experience mild dizziness and fatigue, which the team suspected might be related to the medication adjustments or potential dehydration due to improved diuresis from better blood pressure control.

To address these new symptoms, the clinical team conducted further assessments, including electrolyte panels and hydration status, to rule out any electrolyte imbalances or dehydration. The results showed a mild hyponatremia, with sodium levels at 133 mmol/L, possibly linked to the increased diuretic effect of her hypertension management. This finding prompted the team to adjust her fluid intake and consider modifying her medication regimen further to balance the therapeutic benefits and potential side effects. The team also emphasized the importance of patient education, reinforcing the need for consistent medication adherence, dietary adjustments, and regular follow-up appointments to ensure continued progress and prevent future complications. The patient's journey illustrates the intricate balance required in managing multiple chronic conditions and the need for ongoing assessment and adjustment of her treatment plan.

Section 3

As the clinical team continued to monitor the patient's progress, a new complication arose that necessitated further attention. Despite the initial success in reducing seizure frequency, the patient began experiencing episodes of confusion and memory lapses, particularly in the late afternoon. These cognitive changes were subtle at first but became more noticeable to both the patient and the healthcare providers. A thorough neurological assessment was conducted, revealing slight disorientation to time and difficulty recalling recent events. Her family noted increased difficulty in performing routine tasks, which was uncharacteristic for her.

Concerned about these cognitive changes, the team ordered a series of diagnostic tests, including an EEG and a comprehensive metabolic panel. The EEG showed no new epileptiform activity, suggesting that the seizures were under control. However, the metabolic panel revealed a BUN level of 28 mg/dL and creatinine of 1.4 mg/dL, indicating the onset of mild renal impairment, which could be contributing to her confusion. This renal change was possibly linked to the increased use of medications, particularly those aiding in hypertension management, and raised concerns about potential drug accumulation or altered pharmacokinetics.

In response, the clinical team adjusted the patient's medication regimen to better accommodate her renal function, reducing the dose of carbamazepine and considering an alternative antihypertensive agent that posed less risk to her kidneys. They also optimized her hydration strategy to support renal clearance and prevent further cognitive decline. This adjustment aimed to maintain the delicate balance of managing her epilepsy, hypertension, and diabetes while addressing her new cognitive symptoms. The patient's care plan was updated to include regular cognitive assessments and renal function monitoring, emphasizing a multidisciplinary approach to ensure comprehensive management of her complex health needs.

Section 4

As the clinical team continued to observe the patient following the adjustment of her medication regimen, they noted a temporary improvement in her cognitive symptoms. However, within a week, the patient began to exhibit new complications. She developed mild peripheral edema and reported episodes of dizziness upon standing, suggesting potential orthostatic hypotension. Vital signs revealed a blood pressure of 98/65 mmHg when standing, compared to 120/80 mmHg when lying down, confirming the suspicion of postural hypotension. Additionally, her heart rate increased to 110 beats per minute upon standing, indicative of compensatory tachycardia.

These new symptoms prompted the team to reassess her current medication regimen, particularly the recent changes to her antihypertensive therapy. The possibility of the new agent contributing to her hypotensive episodes was considered, necessitating a further fine-tuning of her medications. Meanwhile, her renal function tests were repeated, showing a slight improvement in her BUN level to 26 mg/dL and stable creatinine at 1.3 mg/dL, indicating that her renal impairment was being managed effectively.

Recognizing the need for a nuanced approach, the team consulted with a cardiologist to evaluate the potential need for an alternative antihypertensive strategy that would not exacerbate her hypotension. A gradual titration of her antihypertensive medication was planned, with close monitoring of her blood pressure and heart rate. This careful adjustment aimed to stabilize her cardiovascular status while preventing further cognitive or renal complications. The patient's care plan was updated to include daily orthostatic blood pressure monitoring and adjustment of diuretics to manage her edema, paving the way for a comprehensive, multi-faceted approach to her complex clinical picture.

Section 5

As the clinical team continued to monitor the patient closely, attention was directed towards the new diagnostic results from the ongoing assessments. A repeat orthostatic blood pressure test was performed, which confirmed persistent orthostatic hypotension with a standing blood pressure of 95/60 mmHg and a notable heart rate increase to 115 beats per minute. To further elucidate the cause of her symptoms, an echocardiogram was conducted, which revealed mild left ventricular hypertrophy without significant valvular abnormalities, suggesting a chronic adaptation to previous hypertension. Moreover, a 24-hour Holter monitor was ordered to assess for any arrhythmic contributions to her dizziness, but initial findings showed no significant arrhythmias.

Laboratory investigations were expanded to include serum electrolytes, given the patient's use of diuretics. Results showed a serum sodium level of 134 mmol/L and potassium level of 3.2 mmol/L, indicating mild hyponatremia and hypokalemia. These electrolyte imbalances were likely contributing to her symptoms of dizziness and required prompt correction. The clinical team decided to adjust her diuretic regimen, reducing the dosage to mitigate further electrolyte disturbances and prevent exacerbation of her hypotensive episodes. Additionally, electrolyte supplements were initiated to correct the deficiencies.

The patient's response to these interventions was closely observed. Over the next several days, with adjustments to her medication regimen and careful monitoring of fluid and electrolyte balance, the patient reported a decrease in dizziness and an improvement in her peripheral edema. Her standing blood pressure stabilized to 102/70 mmHg, with a heart rate of 100 beats per minute, indicating a positive response to the tailored treatment plan. However, the team remained vigilant for any new complications, particularly in light of her underlying seizure disorder and the potential for further cardiovascular or renal challenges. This ongoing assessment and adjustment underscored the importance of a dynamic and responsive approach to her complex clinical needs.